Discontinuation report SODIUM IODIDE I 131 ORAL SOLUTION
| Report ID | 92069 |
| Drug Identification Number | |
| Brand name | SODIUM IODIDE I 131 ORAL SOLUTION |
| Common or Proper name | SODIUM IODIDE I 131 ORAL SOLUTION |
| Company Name | MALLINCKRODT RP CANADA INC |
| Market Status | |
| Active Ingredient(s) | SODIUM IODIDE I 131 |
| Strength(s) | 5mCi, 10mCi, 20mCi, 25mCi, 35mCi, 50mCi, 100mCi, 150mCi, 75mCi |
| Dosage form(s) | Solution |
| Route of administration | Oral |
| Packaging size | All |
| ATC code | V09FX |
| ATC description | Thyroid |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | |
| Actual discontinuation date | 2019-08-20 |
| Remaining supply date | 2019-08-20 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | Curium Canada Inc 2572 Daniel-Johnson boulevard, Suite 248, Laval, Québec, H7T-2R3 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2019-08-21 | French | Compare |
| v1 | 2019-08-21 | English | Compare |
Showing 1 to 2 of 2